Transcript Programma Scientifico

SCIENTIFIC
PROGRAMME
HIV and COINFECTIONS
3rd ICONA FOUNDATION MEETING
ROME
January 26-27, 2017
Auditorium Via Veneto
Scientific Coordinators
Andrea Antinori
Antonella Castagna
Francesca Ceccherini-Silberstein
Alessandro Cozzi-Lepri
Antonella d’Arminio Monforte
Enrico Girardi
Sergio Lo Caputo
Italian
Cohort
Cristina Mussini
I.
C
O.
Massimo Puoti
N
A.
Naive
Antiretrovirals
Fondazione Icona
ITALIAN COHORT NAIVE ANTIRETROVIRALS
Conceived by Professor Mauro Moroni
I.
C
N
O.
A.
HEPA
Hepatitis Icona Cohort
HIV and COINFECTIONS
3rd ICONA FOUNDATION MEETING
ICONA FOUNDATION
STUDY GROUP
Board of Directors
A. d'Arminio Monforte (President), A. Antinori, A. Castagna, F. Castelli, R. Cauda, G. Di Perri,
M. Galli, R. Iardino, G. Ippolito, G.M. Marchetti, C.F. Perno, F. von Schlösser, P. Viale
Presidential Commitee
A. Antinori, A. d'Arminio Monforte, G. Ippolito, A. Lazzarin, C.F. Perno
Scientific Secretary
A. Antinori, A. d'Arminio Monforte, A. Castagna, F. Ceccherini-Silberstein, A. Cozzi-Lepri, E. Girardi,
S. Lo Caputo, C. Mussini, M. Puoti
Scientific Committee
A. Ammassari, M. Andreoni, A. Antinori, A. d'Arminio Monforte, C. Balotta, A. Bandera, P. Bonfanti,
S. Bonora, M. Borderi, A. Calcagno, L. Calza, M.R. Capobianchi, A. Castagna, F. Ceccherini-Silberstein,
A. Cingolani, P. Cinque, A. Cozzi-Lepri, A. De Luca, A. Di Biagio, N. Gianotti, E. Girardi, A. Gori,
G. Guaraldi, G. Lapadula, M. Lichtner, S. Lo Caputo, G. Madeddu, F. Maggiolo, G. Marchetti,
S. Marcotullio, L. Monno, C. Mussini, S. Nozza, M. Puoti, E. Quiros Roldan, R. Rossotti, S. Rusconi,
M. Santoro, A. Saracino, M. Zaccarelli
Statistical and Monitoring Team
A. Cozzi-Lepri, I. Fanti, L. Galli, P. Lorenzini, A. Rodano, M. Shanyinde, A. Tavelli
Biological Bank INMI
F. Carletti, S. Carrara, A. Di Caro, S. Graziano, F. Petrone, G. Prota, S. Quartu, S. Truffa
SFACULTY
CIENTIFIC
P RMassimo
O GofAndreoni
RTorAVergata,
MM
E
University
Rome
Maria Rosaria Iardino
NPS Italia Onlus, Milan
Gioacchino Angarano
Giuseppe Ippolito
University Hospital of Bari
IRCCS INMI Lazzaro Spallanzani, Rome
Andrea Antinori
Adriano Lazzarin
IRCCS INMI Lazzaro Spallanzani, Rome
San Raffaele Hospital, Milan
Stefania Carrara
Sergio Lo Caputo
IRCCS INMI Lazzaro Spallanzani, Rome
University Hospital of Bari
Antonella Castagna
Patrizia Lorenzini
San Raffaele Hospital, Milan
IRCCS INMI Lazzaro Spallanzani,
Rome
Francesco Castelli
University of Brescia
Franco Maggiolo
Roberto Cauda
ASST Papa Giovanni XXIII, Bergamo
Catholic University, Rome
Giulia Marchetti
Francesca Ceccherini-Silberstein
University of Tor Vergata, Rome
ASST S. Paolo and Carlo, San Paolo Hospital,
University of Milan
Antonella Cingolani
Simone Marcotullio
Catholic University, Rome
NADIR Onlus, Rome
Alessandro Cozzi-Lepri
Simona Montilla
Royal Free & University College Medical School,
University College of London UK
AIFA Agenzia Italiana del Farmaco, Rome
Cristina Mussini
Davide Croce
Carlo Cattaneo University LIUC, Castellanza VA
University Hospital of Modena and Reggio Emilia,
Modena
Antonella d’Arminio Monforte
Carlo Federico Perno
ASST S. Paolo and Carlo, San Paolo Hospital,
University of Milan
University of Tor Vergata, Rome
Carmela Pinnetti
Andrea De Luca
IRCCS INMI Lazzaro Spallanzani, Rome
University Hospital of Siena
Massimo Puoti
Antonio Di Biagio
Niguarda Ca’ Granda Hospital, Milan
IRCCS AOU San Martino-IST, Genoa
Stefano Rusconi
Iuri Fanti
Catholic University, Rome
ASST Fatebenefratelli Sacco, Luigi Sacco Hospital,
University of Milan
Massimo Galli
Annalisa Saracino
ASST Fatebenefratelli Sacco, Luigi Sacco Hospital,
University of Milan
University Hospital of Bari
Milensu Shanyinde
Ivan Gardini
EpaC Onlus, Vimercate MB
Royal Free & University College Medical School,
University College of London UK
Enrico Girardi
Gloria Taliani
IRCCS INMI Lazzaro Spallanzani, Rome
Sapienza University, Rome
Andrea Gori
Alessandro Tavelli
San Gerardo Hospital, University of Milano-Bicocca, Monza
Giovanni Guaraldi
University Hospital of Modena and Reggio Emilia,
Modena
ASST S. Paolo and Carlo, San Paolo Hospital,
University of Milan
Mauro Zaccarelli
IRCCS INMI Lazzaro Spallanzani, Rome
HIV and COINFECTIONS
3rd ICONA FOUNDATION MEETING
10.00-11.00
Registration
Thursday, January 26, 2017
11.00-11.15
Introduction: rationale and aims of the third ICONA Meeting
A. Antinori, A. d’Arminio Monforte, M. Puoti
11.15-13.15
Round Table
Chairs: A. Antinori, F. Ceccherini-Silberstein
Coinfection HIV-HCV: a public health problem and available
resources
Participants: D. Croce, A. d’Arminio Monforte, I. Gardini, M.R. Iardino,
S. Marcotullio, S. Montilla, M. Puoti
13.15-14.00 Lunch
14.00-14.45
Main Lectures
Chair: F. Castelli
14.00-14.30
HIV therapy: what’s new? M. Andreoni
14.30-14.45
Special communication
A survey on HIV/HCV Italian people: the denial of DAAs therapy
S. Marcotullio
SCIENTIFIC
PROGRAMME
Session 1
ICONA and HepaICONA research in HIV and HIV-HCV coinfection
Chairs: M. Galli, A. Lazzarin
14.45-15.00
15.00-15.15
ART use and risk of ALT elevation in HIV/HCV co-infected patients M. Shanyinde
Multiple lines of antiretroviral therapy in relation to HCV co-infections
G. Marchetti
15.15-15.30
15.30-15.45
15.45-16.00
Durability and tolerability of first-line combination including RAL
or ATV/r or DRV/r P. Lorenzini
Prescription pattern and determinants of Dolutegravir use
in naïve HIV-infected patients S. Lo Caputo
Survival in HIV+ patients with lymphoma compared to general population
A. Cingolani
16.00-16.15
16.15-16.30
Impact of social determinants on ART A. Saracino
Discussion
16.30-16.45 Coffee break
Main Lectures
17.15-17.35
Analyzing current trends of HIV epidemic: the role of cohort studies E. Girardi
The management of DAA failure C.F. Perno
Session 2
ICONA and HepaICONA research in HIV and HIV-HCV coinfection
16.45-17.15
Chairs: G. Angarano, C.F. Perno
17.35-17.50
Reducing Pill Burden vs. Drug Burden as Strategy of ART Simplification
M. Zaccarelli
17.50-18.05
CD4/CD8 Ratio in Patients switching Triple vs Dual/Mono Therapy
C. Mussini
18.05-18.20
HIV-positive subjects treated with the STR cobicistat, elvitegravir,
emtricitabine and tenofovir when ART-naïve in clinical practice
A. Cozzi-Lepri
18.20-18.35
Discussion
18.35-19.00
Final considerations A. Antinori, A. d’Arminio Monforte, M. Puoti
HIV and COINFECTIONS
3rd ICONA FOUNDATION MEETING
Friday, January 27, 2017
08.30-09.30
ICONA and HepaICONA research projects
Chairs: R. Cauda, G. Ippolito
08.30-09.00
Non-Interventional Observational Study in HIV positive patients from Italy,
receiving emtricitabine/tenofovir alafenamide based regimens: correlation
of safety and efficacy with clinical and immune virologic parameters and PROs
C. Pinnetti
09.00-09.30
Patient-reported outcomes measurement in the ICONA study A. Cingolani
09.30-11.30
Parallel Workshops on data from ICONA and HepaICONA reports
Sala A
Auditorium
10.30-11.30 Auditorium
Sala A
09.30-10.30
11.30-12.30
Workshop 1 Epidemiology A. Cingolani, E. Girardi, A. Saracino
Workshop 2 Coinfections A. De Luca, M. Puoti, G. Taliani
Workshop 3 HIV Therapy A. Di Biagio, F. Maggiolo, S. Rusconi
Workshop 4 HIV Comorbidities A. Gori, G. Guaraldi, G. Marchetti
Wrap-up from parallel Workshops
Chairs: A. Castagna, C. Mussini
12.15-12.30
Workshop 1 Epidemiology A. Cingolani, E. Girardi, A. Saracino
Workshop 2 Coinfections A. De Luca, M. Puoti, G. Taliani
Workshop 3 HIV Therapy A. Di Biagio, F. Maggiolo, S. Rusconi
Workshop 4 HIV Comorbidities A. Gori, G. Guaraldi, G. Marchetti
12.30-13.50
Open discussion among ICONA and HepaICONA Centres
11.30-11.45
11.45-12.00
12.00-12.15
Facilitators: S. Carrara, I. Fanti, A. Tavelli
13.50-14.00
Final considerations A. Antinori, A. d’Arminio Monforte, M. Puoti
14.00
Lunch
SCIENTIFIC
PROGRAMME
GENERAL INFORMATION
Venue
Auditorium Via Veneto
Via Veneto, 89 - 00187 Rome I
www.auditoriumviaveneto.it
Crediti ECM
La Commissione Nazionale per la Formazione Continua in Medicina ha
assegnato n. 11 crediti formativi al Meeting (N. ECM 150-175350) per Biologi,
Farmacisti ospedalieri e territoriali e Medici Specialisti in Malattie Infettive, Microbiologia
e Virologia, Igiene, Epidemiologia e Sanità Pubblica, Direzione Medica di Presidio
Ospedaliero, Allergologia e Immunologia Clinica, Medicina Interna e Gastroenterologia.
L’assegnazione dei crediti formativi è subordinata alla presenza al 90% dei lavori e alla
corretta compilazione di almeno il 75% delle domande proposte all’interno del questionario
di valutazione finale. È inoltre obbligatoria la rilevazione delle presenze e la compilazione
del questionario di valutazione e di gradimento dell’evento formativo.
CME Provider and Organizing Secretariat
Effetti Srl
Via Gallarate, 106 - 20151 Milan, Italy
Phone +39 02 3343281 - Fax +39 02 38002105
Mail: [email protected]
www.effetti.it - www.fondazioneicona.org
HIV and COINFECTIONS
3rd ICONA FOUNDATION MEETING
THANKS TO THE SPONSORS
The ICONA Foundation, the Scientific Coordinators and the CME Provider wish to
thank for support given in the form of unrestricted educational grants the following Companies:
PLATINUM SPONSOR
SILVER SPONSORS